124 related articles for article (PubMed ID: 6634874)
1. Drug-induced changes in motor activity after selective MAO inhibition.
Gianutsos G; Carlson GM; Godfrey JG
Pharmacol Biochem Behav; 1983 Aug; 19(2):263-8. PubMed ID: 6634874
[TBL] [Abstract][Full Text] [Related]
2. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
Green AR; Youdim MB
Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
[TBL] [Abstract][Full Text] [Related]
3. Effect of the monoamine oxidase inhibitors clorgyline and pargyline on the hyperphagia of obese mice.
Feldman JM
Behav Brain Res; 1988 Jul; 29(1-2):147-58. PubMed ID: 2840925
[TBL] [Abstract][Full Text] [Related]
4. Selectivity of clorgyline and pargyline as inhibitors of monoamine oxidases A and B in vivo in man.
Murphy DL; Lipper S; Slater S; Shiling D
Psychopharmacology (Berl); 1979 Apr; 62(2):129-32. PubMed ID: 111275
[TBL] [Abstract][Full Text] [Related]
5. Effect of moclobemide on rat brain monoamine oxidase A and B: comparison with harmaline and clorgyline.
Gerardy J
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):793-802. PubMed ID: 7938567
[TBL] [Abstract][Full Text] [Related]
6. Monoamine oxidase inhibitors potentiate phenylethylamine effects in rhesus monkeys.
Staub RA; Gillin JC; Wyatt RJ
Biol Psychiatry; 1980 Jun; 15(3):429-36. PubMed ID: 6769508
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.
Di Monte DA; DeLanney LE; Irwin I; Royland JE; Chan P; Jakowec MW; Langston JW
Brain Res; 1996 Oct; 738(1):53-9. PubMed ID: 8949927
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
[TBL] [Abstract][Full Text] [Related]
9. Alteration of dopamine synthesis in rat striatum subsequent to selective type A monoamine oxidase inhibition.
Schoepp DD; Azzaro AJ
J Neurochem; 1981 Aug; 37(2):527-30. PubMed ID: 6790675
[TBL] [Abstract][Full Text] [Related]
10. MD 240928 and harmaline: opposite selectivity in antagonism of the inactivation of types A and B monoamine oxidase by pargyline in mice.
Fuller RW; Wong CJ; Hemrick-Luecke SK
Life Sci; 1986 Feb; 38(5):409-12. PubMed ID: 3945167
[TBL] [Abstract][Full Text] [Related]
11. Preferential deamination of dopamine by an A type monoamine oxidase in rat brain.
Waldmeier PC; Delini-Stula A; Maître L
Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(1):9-14. PubMed ID: 934359
[TBL] [Abstract][Full Text] [Related]
12. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
Severina IS
Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
[TBL] [Abstract][Full Text] [Related]
13. Comparison of short and long-lasting effects of pargyline on cerebral dopamine metabolism.
Waldmeier PC; Maître L
Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug; 294(2):133-40. PubMed ID: 1012333
[TBL] [Abstract][Full Text] [Related]
14. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
Lamensdorf I; Youdim MB; Finberg JP
J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
[TBL] [Abstract][Full Text] [Related]
15. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.
Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
J Neurochem; 1990 Sep; 55(3):981-8. PubMed ID: 2117053
[TBL] [Abstract][Full Text] [Related]
16. Interaction between cytosolic monoamine oxidase and spin-labeled amphetamine and its modification by clorgyline and pargyline.
Copeland ES; Campbell IC; Murphy DL
Biochim Biophys Acta; 1983 Feb; 743(1):186-94. PubMed ID: 6824699
[TBL] [Abstract][Full Text] [Related]
17. Specificity of endogenous substrates for types A and B monoamine oxidase in rat striatum.
Schoepp DD; Azzaro AJ
J Neurochem; 1981 Jun; 36(6):2025-31. PubMed ID: 6787175
[TBL] [Abstract][Full Text] [Related]
18. Developmental changes in the activity and substrate specificities of mouse brain monoamine oxidase.
Koide Y; Kobayashi K
Neurochem Res; 1984 May; 9(5):595-606. PubMed ID: 6472564
[TBL] [Abstract][Full Text] [Related]
19. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
Severina IS; Klimova GI; Nersisian AA
Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks.
Barbelivien A; Nyman L; Haapalinna A; Sirviö J
Pharmacol Toxicol; 2001 Jun; 88(6):304-12. PubMed ID: 11453370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
